论文部分内容阅读
目的:探讨拉米夫定治疗肝功能失代偿乙型肝炎肝硬化的效果。方法:将78例诊断为肝功能失代偿乙型肝炎肝硬化的患者分为两组,两组患者均予以抗炎保肝等常规治疗,观察组患者在常规治疗的基础上加用拉米夫定。对两组患者治疗前后肝功能以及血清学标志物阴转情况进行观察和比较判断分为显效、有效和无效。结果:观察组治疗显效、有效率均优于对照组(P<0.05)。结论:拉米夫定治疗乙型肝炎肝硬化失代偿期明显的效果。
Objective: To investigate the effect of lamivudine in the treatment of liver cirrhosis due to decompensation of liver function. Methods: 78 patients diagnosed as decompensated hepatitis B liver cirrhosis patients were divided into two groups, two groups of patients were given anti-inflammatory and liver and other conventional treatment, the observation group patients on the basis of conventional treatment plus Lamy Fuding. The two groups of patients before and after treatment of liver function and serological markers of negative conversion were observed and compared judgments were divided into markedly effective, effective and ineffective. Results: The observation group was significantly better than the control group (P <0.05). Conclusion: Lamivudine treatment of hepatitis B cirrhosis decompensated significant effect.